Katie Patton

Katie Patton researches federal and state health policy developments and supports Avalere’s 360 research series, which provides clients with analysis, insights, and educational resources related to emerging trends in healthcare.

She applies her background in public health to support a broad range of client projects.

Prior to joining Avalere full time, Katie was an intern, providing support to Avalere’s business intelligence products. Additionally, she has worked in various healthcare settings where she directly delivered patient care and served as a patient services coordinator.

Katie has a BS in public health from the University of Maryland, College Park.

Authored Content

While the majority of state legislative sessions have adjourned for 2019, at least 11 states (CT, FL, LA, IN, MD, ME, NH, NM, NV, VT, and WA) have enacted laws to create or study coverage protections against pre-existing condition exclusions and coverage of all essential health benefits (EHB) provided for in the Affordable Care Act (ACA).

While the Department of Health & Human Services (HHS) did not intend for proposed changes to Anti-Kickback Statute (AKS) regulations to impact commercial market drug negotiations, some state laws may indirectly lead to commercial market implications.

Healthcare spending is expected to represent 19.4% of US GDP in 2027.